Operator
Greetings, and welcome to Vaxart’s Stockholder Fireplace Chat Convention Name. (Operator Directions) As a reminder, this convention is being recorded.
I’d now like to show the webcast over to David Carey, Finn Companions.
David Carey
Finn Companions, Inc.
Good afternoon, and welcome to right now’s name. Becoming a member of us from Vaxart are Steve Lo, Chief Govt Officer; Dr. Sean Tucker, Founder and Chief Scientific Officer; Dr. James S. Cummings, Chief Medical Officer; Jeroen Grasman, Chief Monetary Officer; and Ed Berg, Senior Vice President and Normal Counsel.
Earlier than we start, I want to remind everybody that in this convention name, Vaxart could make forward-looking statements, together with statements concerning the firm’s monetary outcomes, monetary steering, its future enterprise methods and operations, any partnerships with third events, timing of any anticipated regulatory approvals or that any such approval shall be obtained, the corporate’s future money runway, capacity to regain compliance with NASDAQ itemizing requirements or elevate capital if such itemizing is regained, and its product growth and regulatory progress, together with statements about its ongoing or deliberate scientific trials.
Precise outcomes might materially differ from these mentioned in these forward-looking statements resulting from numerous vital components, together with uncertainty inherent within the scientific growth and regulatory course of and different dangers described within the Danger Components part of Vaxart’s most not too long ago filed annual report on Kind 10-Ok and in addition on different periodic reviews filed with the SEC. Vaxart undertakes no obligation to replace